HealthEquity, Inc. (HQY) Guidance & Earnings Results

On 2026-08-27 HealthEquity, Inc. raised guidance: "FY27 revenue raised to $1.411-1.421B; net income $242-248M ($2.88-2.96 per diluted share); non-GAAP net income $392-398M ($4.66-4.73 per diluted share); Adjusted EBITDA…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

HQYHealthEquity, Inc.Follow HQY — free

Health Information Services · Healthcare

—

Price chart with a free account

Market cap: 8.6B
P/E TTM: 37.5
Dividend yield: —
52-week: —
Next earnings: 1 Dec, in 38 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
27 Aug 26	Raised	FY27 revenue raised to $1.411-1.421B; net income $242-248M ($2.88-2.96 per diluted share); non-GAAP net income $392-398M ($4.66-4.73 per diluted share); Adjusted EBITDA $628-636M · full year
28 May 26	Raised	FY2027 revenue guidance $1.41-1.42B; Adjusted EBITDA $625-633M · full year
17 Mar 26	Raised	FY2027 revenue $1.405-1.415B; Adj. EBITDA $618-628M · full year
17 Feb 26	Reaffirmed	FY2026 results expected near top end of ranges; FY2027 guidance reaffirmed · full year
3 Dec 25	Raised	Revenue guidance $1.302B-$1.312B; Adjusted EBITDA $555M-$565M · full year
2 Sep 25	Raised	FY26 revenue $1.29-1.31B, Adj EBITDA $540-560M · full year

HealthEquity, Inc. — questions

What guidance did HealthEquity, Inc. give?: On 2026-08-27: "FY27 revenue raised to $1.411-1.421B; net income $242-248M ($2.88-2.96 per diluted share); non-GAAP net income $392-398M ($4.66-4.73 per diluted share); Adjusted EBITDA $628-636M"
When does HealthEquity, Inc. report earnings?: HealthEquity, Inc.'s next earnings report is expected on 2026-12-01.

Every figure on this page comes from HealthEquity, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.